A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver
Clinical trial NCT00906373 · COMPLETED
Trial details
- NCT number
- NCT00906373
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2012-10-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.